8H0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PolyPeptide Group AG

Watchlist Manager

Watchlist

Price: 46.8 EUR 0.43%

Market Cap: €1.6B

	PolyPeptide Group AG F:8H0	CH
H	Heartland Group Holdings Ltd F:73X	NZ
A	Avis Budget Group Inc SWB:CUCA	US
	AVITA Medical Inc OTC:AVHHL	US

Profitability Summary

PolyPeptide Group AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

11%

Gross Margin is Increasing

2% > 17%

Low Operating Margin

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-13% > 3%

Negative Net Margin

-5%

Negative 3Y Average Net Margin

-9%

Net Margin is Increasing

-13% > -5%

Negative Free Cash Flow Margin

-8%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-37% > -8%

Negative ROE

-6%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-6% > 2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.